These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25323929)

  • 1. Drug Delivery: Non-invasive drug depot refill.
    Flemming A
    Nat Rev Drug Discov; 2014 Nov; 13(11):810-1. PubMed ID: 25323929
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug delivery: replenishing reservoirs in vivo.
    Couvreur P
    Nat Nanotechnol; 2014 Nov; 9(11):874-5. PubMed ID: 25370424
    [No Abstract]   [Full Text] [Related]  

  • 3. Refilling drug delivery depots through the blood.
    Brudno Y; Silva EA; Kearney CJ; Lewin SA; Miller A; Martinick KD; Aizenberg M; Mooney DJ
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12722-7. PubMed ID: 25139997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framework nucleic acids as programmable carrier for transdermal drug delivery.
    Wiraja C; Zhu Y; Lio DCS; Yeo DC; Xie M; Fang W; Li Q; Zheng M; Van Steensel M; Wang L; Fan C; Xu C
    Nat Commun; 2019 Mar; 10(1):1147. PubMed ID: 30850596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell-based drug delivery system for lung targeting: I. Preparation and pharmacokinetics.
    Shao J; DeHaven J; Lamm D; Weissman DN; Runyan K; Malanga CJ; Rojanasakul Y; Ma JK
    Drug Deliv; 2001; 8(2):61-9. PubMed ID: 11400864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based drug delivery system for lung targeting: II. Therapeutic activities on B16-F10 melanoma in mouse lungs.
    Shao J; DeHaven J; Lamm D; Weissman DN; Malanga CJ; Rojanasakul Y; Ma JK
    Drug Deliv; 2001; 8(2):71-6. PubMed ID: 11400865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots.
    Bajwa N; Kumar Mehra N; Jain K; Kumar Jain N
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1774-82. PubMed ID: 26508412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes.
    Pegoraro C; Cecchin D; Gracia LS; Warren N; Madsen J; Armes SP; Lewis A; Macneil S; Battaglia G
    Cancer Lett; 2013 Jul; 334(2):328-37. PubMed ID: 23402813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.
    Ryu JS; Kratz F; Raucher D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
    Zhang LS; Greyner HJ; Mummert ME; Petroll WM
    J Dermatol Sci; 2009 Jul; 55(1):56-9. PubMed ID: 19346104
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC
    J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
    Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
    Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin for metastatic breast cancer: time for a change?
    Muggia F
    Cancer Invest; 2003; 21(6):967-8. PubMed ID: 14735701
    [No Abstract]   [Full Text] [Related]  

  • 14. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines.
    Zhang Y; Chen W; Yang C; Fan Q; Wu W; Jiang X
    J Control Release; 2016 Sep; 237():115-24. PubMed ID: 27397491
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin.
    Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ
    J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
    Harasym TO; Cullis PR; Bally MB
    Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.
    Weinberg BD; Patel RB; Exner AA; Saidel GM; Gao J
    J Control Release; 2007 Dec; 124(1-2):11-9. PubMed ID: 17900740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.